CSIMarket Company Name, Ticker, Industry, else..
 
Treace Medical Concepts Inc   (NASDAQ: TMCI)
 
Price: $2.8600 $0.08 2.878%
Day's High: $2.89 Week Perf: 4.38 %
Day's Low: $ 2.74 30 Day Perf: -19.66 %
Volume (M): 839 52 Wk High: $ 10.79
Volume (M$): $ 2,398 52 Wk Avg: $6.83
Open: $2.76 52 Wk Low: $2.56



 Market Capitalization (Millions $) 182
 Shares Outstanding (Millions) 64
 Employees 329
 Revenues (TTM) (Millions $) 219
 Net Income (TTM) (Millions $) -50
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 14

Treace Medical Concepts Inc
Treace Medical Concepts Inc is a medical device company that focuses on developing innovative solutions for foot and ankle conditions. The company is known for its Laser Loc' and Lapiplasty' product lines, which aim to advance the standard of care for the treatment of various foot and ankle conditions, including bunions and hammertoes. Treace Medical Concepts Inc strives to provide surgeons and patients with improved surgical approaches and outcomes through their technologically advanced and minimally invasive products.


   Company Address: 100 Palmetto Park Place Ponte Vedra 32081 FL
   Company Phone Number: 373-5940   Stock Exchange / Ticker: NASDAQ TMCI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Announcement

Navigating Uncertainties The Pomerantz Investigation and Treace Medicals Market Performance

Published Fri, Apr 25 2025 7:30 PM UTC

Navigating Uncertainties: The Pomerantz Investigation and Treace Medical s Market Performance As the financial markets continue to fluctuate, investors are keenly observing developments involving Treace Medical Concepts, Inc. (NASDAQ: TMCI). This month, Pomerantz LLP, a well-respected law firm specializing in securities litigation, announced its investigation into potential ...
Clinical Study

Revamping Bunion Surgery Insights from Treace Medicals Latest Clinical Study Outcomes at ACFAS 2025

Published Fri, Mar 28 2025 6:50 PM UTC

In the evolving field of podiatric surgery, Treace Medical Concepts, Inc. has emerged as a pioneer with its innovative solutions for treating bunions and midfoot deformities. The recent presentation of clinical study data at the 2025 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting in Phoenix, Arizona, signifies an important milestone for the company. By sh...
Product Service News

Treace Medical Concepts Expands Surgical Portfolio with Innovative Bunion and Osteotomy Solutions

Published Mon, Dec 30 2024 5:40 PM UTC

Treace Medical Concepts Inc. has announced the expansion of its product portfolio into the high-volume osteotomy market with the introduction of its second minimally invasive surgical (MIS) osteotomy platform. The company aims to solidify its presence in the competitive bunion correction field through its new Percuplasty procedure, which utilizes a percutaneous 3D approach f...
Product Service News

Treace Medical Concepts Achieves Milestone with First Successful Surgeries Using SpeedPlate MicroQuad Implants

Published Sun, Dec 29 2024 6:55 PM UTC

In a significant advancement for foot and ankle surgery, Treace Medical Concepts, Inc. (Treace), a company at the forefront of medical technology innovation, announced the completion of the first successful surgical cases utilizing their newly released SpeedPlate MicroQuad implants. This breakthrough marks a pivotal point in Treace s continuous endeavor to revolutionize the ...
Product Service News

A Step Ahead Treace Medical Concepts Pioneers Personalized Solutions for Midfoot Deformities,

Published Wed, Dec 4 2024 9:15 PM UTC

The field of orthopedic surgery has witnessed a groundbreaking leap with the announcement by Treace Medical Concepts, Inc. (NasdaqGS: TMCI). On December 4, 2024, the company unveiled its successful deployment of a pioneering surgical approach that integrates its IntelliGuide Patient Specific Instrumentation (PSI) technology with the Adductoplasty System, specifically designe...






Treace Medical Concepts Inc's Segments

  Treace Medical Concepts Inc Outlook

On February 27 2024 the Treace Medical Concepts Inc provided following guidance

Treace Medical Concepts, Inc. (Treace) recently released its financial results for the fourth quarter and full year ended December 31, 2023. The company, which is listed on NasdaqGS under the ticker symbol TMCI, is a leading medical technology firm that is revolutionizing the surgical treatment of bunions and related midfoot deformities with its flagship procedures, Lapiplasty and Adductoplasty.

According to the financial report, Treace experienced strong performance in 2023, with significant growth in revenue and profits. The company's innovative procedures have gained widespread recognition in the medical community and have helped to drive its success in the market.

Looking ahead to 2024, Tre...





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.